Search company, investor...


Private Equity | Alive

Total Raised


Last Raised

$17.54M | 6 yrs ago

About Hadean Ventures

Hadean Ventures is a life science venture capital fund manager, operating in the healthcare industry. The company invests in a broad range of healthcare verticals and stages, focusing on products that have the potential to address unmet medical needs. Its primary customer segments include specialty pharmaceuticals, medical technology, diagnostics, and digital health. It is based in Oslo, Norway.

Headquarters Location

Dronningen 1

Oslo, NO-0287,


+47 24115722



Latest Hadean Ventures News

Dr. Klaus Hommels of Lakestar assumes role of Invest Europe Chair

Oct 25, 2023

14 Jun 2022 Board appointments from Argos Wityu, Forbion, Hadean Ventures and Hermes GPE Invest Europe, the association representing Europe’s private equity, venture capital and infrastructure sectors, as well as their investors, announced that Dr. Klaus Hommels, founder of Lakestar , has assumed the role of Chair for 2022-2023, taking over from Anne Fossemalle, Director, Equity Funds at the European Bank for Reconstruction and Development . Invest Europe took the opportunity to offer its heartfelt thanks to Anne - on behalf of its members and broader network - for her tireless work to promote the industry, and its contributions to Europe’s economy and society ‘as a force for good.’ Klaus is one of Europe’s leading business angels and venture capitalists and was an early investor in European technology champions including Spotify, Klarna, Sumup and Revolut, as well as international leaders Airbnb and Facebook. He founded Lakestar in 2012 after previously running his own venture capital fund Hommels Holding. As a passionate advocate on behalf of the European tech ecosystem Klaus is also a founding member of think-tank initiatives including the Internet Economy Foundation and the European Center for Digital Competitiveness in Berlin. Klaus holds a Master’s in Business Administration from the University of Fribourg in Switzerland and holds a PhD in Finance from the same university. As Invest Europe Chair, Klaus will be supported by directors drawn from the association’s broad membership which represents venture capital, mid-market funds, large buyouts and limited partners. Appointments confirmed for a three-year period until June 2025 include Louis Godron ( Argos Wityu ), Sander Slootweg ( Forbion ), Ingrid Teigland Akay ( Hadean Ventures ) who is confirmed as board member for a year until June 2023, and Elias Korosis ( Hermes GPE ). Klaus will also work closely with CEO Eric de Montgolfier and the association’s team to promote and increase understanding about private equity and venture capital’s cornerstone contribution to Europe’s economy and society. His priorities for the year to June 2023 include: 1. Drawing on Invest Europe’s position as the voice of European private equity to propose and drive forward measures to strengthen Europe’s investment ecosystem for all participants, and the economy more broadly.\ 2. Promoting European sovereignty in financing and technology by advocating a step change in equity capital to bridge the funding gap for European industry, and helping identify core technologies to ensure Europe’s digital and technical sovereignty. 3. Supporting and encouraging European entrepreneurship through alignment with European policy and regulatory objectives, as well as the financial sector. The private equity and venture capital industry provided strong support for European businesses and workers throughout the COVID-19 crisis and economic recovery. Almost 10 million people were employed at private equity and venture capital backed businesses across Europe in 2020, according to the third edition of Invest Europe’s groundbreaking Private Equity at Work report , with portfolio companies adding 2% more jobs during a challenging period when the overall European workforce contracted by 1.6%. The industry participated fully in the subsequent economic rebound as firms invested €138 billion in companies throughout the continent, ranging from fledgling SMEs to mature multinationals, a new record and a 51% increase on the previous year. Within that total, investment to support innovation boomed as venture capital funding for start-ups reached €20 billion and growth investment hit €35 billion, both all-time highs. Private equity’s ability to generate strong returns for pension funds and other long-term investors, that in turn support European citizens’ retirements and savings, is also drawing record levels of capital into the industry. Private equity funds attracted €118 billion in new capital in 2021, with record levels of fundraising also seen by venture capital and growth funds. Total fundraising for the last five years exceeds €525 billion, providing the industry with abundant capital to invest in new companies and support existing businesses through ongoing economic, social and geopolitical challenges. Media enquiriesFor more information please contact Eric Drosin

Hadean Ventures Frequently Asked Questions (FAQ)

  • Where is Hadean Ventures's headquarters?

    Hadean Ventures's headquarters is located at Dronningen 1, Oslo.

  • What is Hadean Ventures's latest funding round?

    Hadean Ventures's latest funding round is Private Equity.

  • How much did Hadean Ventures raise?

    Hadean Ventures raised a total of $17.54M.

  • Who are the investors of Hadean Ventures?

    Investors of Hadean Ventures include Argentum Group.

  • Who are Hadean Ventures's competitors?

    Competitors of Hadean Ventures include Horizon Technology Finance and 4 more.


Compare Hadean Ventures to Competitors

Jungle Ventures Logo
Jungle Ventures

Jungle Ventures is a Singapore native global venture capital firm that provides early-stage investments and business building infrastructure to startups. The firm's focus is on seed to early-stage investments. It was founded in 2012 and is based in Singapore.

Carta Ventures

Carta Ventures is a wholly-owned venture capital subsidiary of Carta Holdings, a Japanese media, and advertising technology company. Carta Ventures focuses its efforts on the rapidly growing Asian markets.

Sciety Logo

Sciety is an investment syndicate that offers capital market services with a focus on life science. It specializes in investment, finance, market analysis, and more. It is based in Stockholm, Sweden.

Syncona Partners

Syncona Partners (LON: SYNC) is an investment company. The company offers services that include founding, building, and funding companies. It makes investments in life sciences companies including gene therapy, cell therapy, biologics, and small molecule fields. The company was founded in 2012 and is based in London, U.K.

Medilink UK

Medilink UK is a membership-based professional association and consulting firm that focuses on life science company growth. It uses the combined strengths of its regional partners to assist the growth and development of the life sciences commercial, academic, and clinical communities across the UK. It provides services to the medical device, pharmaceutical, and biotechnology industries. It was founded in 2005 and is based in Nottingham, United Kingdom.

Principia SGR Logo
Principia SGR

Principia is an Italian venture capital firm with an ICT and lifescience investment focus. The company currently manages three investment funds, known as "Principia Fund", "Principia II" and "Principia III – Health" which have collectively made about 40 start-up capital and expansion capital investments.


CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.